XOMA Royalty Corp - Company Profile

Powered by

All the sales intelligence you need on XOMA Royalty Corp in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how XOMA Royalty Corp fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with XOMA Royalty Corp.

Back to companies

XOMA Royalty Corp: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

The following section provides information on XOMA Royalty Corp’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into XOMA Royalty Corp's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Jack L. Wyszomierski

Chairman Executive Board Since: 2024 Age: 69

Mr. Jack L. Wyszomierski has been the Chairman of the company since 2024. Prior to this, he served as the Director of the company. Previously, he served as the Chief Executive Officer of Sail Bio, Inc., Chief Executive Officer and Co-founder of Cullinan Oncology, and Chief Business Officer and Head of Corporate Development at Intarcia Therapeutics, Inc.

Read Hide full bio of Jack L. Wyszomierski

Owen Hughes

Chief Executive Officer; Director Executive Board Since: 2024 Age: 50

Mr. Owen Hughes has been the Chief Executive Officer and Director of the company since 2024. Prior to this, he served as the Chairman, Chief Executive Officer, Co-Founder, and member of the Board of Directors at Cullinan Oncology. Previously, he served as the Chief Business Officer and Head of Corporate Development at Intarcia Therapeutics, Inc. Mr. Hughes also served as the Chairman of the Board of Directors of Ikena Oncology.

Read Hide full bio of Owen Hughes

Jeffrey Trigilio

Chief Financial Officer Senior Management Since: 2026

Mr. Jeffrey Trigilio has been the Chief Financial Officer of the company since January 2026. Prior to this, he served as the Chief Financial and Operating Officer of Obsidian Therapeutics. Mr. Trigilio also served as the Chief Financial Officer at Cullinan Therapeutics.

Read Hide full bio of Jeffrey Trigilio

Brad Sitko

Chief Investment Officer Senior Management Since: 2023 Age: 43

Mr. Brad Sitko has been the Chief Investment Officer of the company since 2023. Prior to this, he served as the Senior Investment Banker at MTS Health Partners.

Read Hide full bio of Brad Sitko

Barbara Kosacz

Director Non Executive Board Since: 2019 Age: 67
Gain a 360-degree view of XOMA Royalty Corp and make more informed decisions for your business Gain a 360-degree view of XOMA Royalty Corp and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer